Recumbent cycling to improve outcomes in people with hip fracture: a feasibility randomized trial

BMC Geriatrics

Table 4 Outcomes at day seven and hospital discharge (median, IQR)

	Bike (n = 26)	Control (n = 25)
Seven day assessment
mILOA	21 (16, 29) (n = 25)	21 (18, 27)
Discharge Assessment
mILOA	8 (6, 13) (n = 24)	9 (6, 15) (n = 24)
Gait Speed (m/s)	0.33 (0.19, 0.50)^a (n = 19, 73%)	0.47 (0.22, 0.58)^b (n = 15, 60%)
MoCA	18 (11, 26) (n = 17)	15 (11, 20) (n = 14)
EQ-5D-3L	.62 (.52, 76) (n = 21)	.61 (.33, .71) (n = 18)
EQ-VAS	62 (50, 80) (n = 18)	53 (9, 80) (n = 18)
Time to reach mobility milestone (days) ^c	9.0 (6.0, 12.0) (n = 22)	10.5 (6.8, 14.0) (n = 22)
Acute LOS	6.0 (4.0, 7.3)	6.0 (5.0, 9.5)
Subacute LOS	22.5 (13.3, 29.8) (n = 20)	17.5 (12.8, 29.5) (n = 22)
Total LOS	20.5 (11.5, 36.3)	23.0 (13.0, 36.5)
Discharge destination
Home	15	13
Residential care	6	8
Other	5	4

mILOA = Modified Iowa Level of Assistance Scale; MoCA = Montreal-Cognitive Assessment; EQ-5D-3 = EuroQol 5D three level; EQ-VAS = EuroQol Visual analogue scale; LOS = length of stay
a. Two participants were unable to perform the test, six participants did not complete the assessment (two died, two no discharge assessment, two no gait assessment)
b. Four participants were unable to perform the test, six participants did not complete the assessment (one died, three no discharge assessment, two no gait assessment).
c. Two people died prior to reaching milestone (one control, one intervention). Five people did not achieve the milestone before discharge (two control, three intervention)

ISSN: 1471-2318